Evaluation of Anti Hyperlipidemic Effect of Zinc Sulfate Alone and in Combination with Atorvastatin in Diet Induced Hyperlipidemic Rats
DOI:
https://doi.org/10.21649/akemu.v31i3.5622Keywords:
Hyperlipidemia, Cardiovascular diseases, zinc sulfate, atorvastatinAbstract
Background: Hyperlipidemia a lipid disorder that affects millions of people worldwide. It is a major contributor for developing cardiovascular diseases.
Objective: To assess the antihyperlipidemic activity of zinc sulfate alone and in combination with atorvastatin in diet induced hyperlipidemic rats.
Methods: Randomized clinical trial was conducted for 8 weeks in Post graduate Medical Institute, Lahore. Thirty -six healthy male albino rats weighing between 100-160mg were randomly divided into 6 groups each having 6 rats. Group A normal control (fed with rat chow) and Group B disease control (fed with high fat diet). Groups C,D,E and F, were experimental groups, fed with high fat diet during the initial four weeks to produce hyperlipidemia and during next four weeks, along with high fat diet (30 mg/kg zinc sulfate orally) was added to Group C, (40 mg/kg Atorvastatin orally) to Group D (30 mg/kg of zinc sulfate + 40 mg/kg atorvastatin) to Group E and (15 mg/kg zinc sulfate +20 mg/kg atorvastatin) to Group F. Blood samples were drawn at 0, 4 and 8 weeks and serum was assessed for lipid profile. Rats were sacrificed at the end of 8 weeks and liver samples examined for histopathological examination.
Results: Disease control group showed significant rise in total cholesterol from 80.17±17.82 at 0 week to 177.17± 15.96, low density lipoprotein from 32.62±17.15 to 102.03±10.88, and triglycerides from 58.17±23.79 to 159.00±39.83 with a p-value of <0.05. All the experimental groups improved lipid profile compared to disease control group a p-value of <0.001. All experimental groups increased high density lipoprotein compared to disease control group, most significant increase was seen in group E (63.00±5.29) with a p-value of 0.010. Histopathological examination showed, 66.7% of rats in disease control group had severe steatosis. Among the experimental groups, Group D had 33.3 % rats while Group C, E, and F had no animal with severe steatosis.
Conclusion: Zinc supplementation alone and in combination with atorvastatin has shown beneficial effects on lipid profile. Zinc sulfate also reduced the fatty alterations of hepatic architecture.
References
1. Mendis S, Graham I, Narula J. Addressing the global burden of cardiovascular diseases; need for scalable and sustainable frameworks. Glob Heart. 2022; 17(1):48. doi:10.5334/gh.1139
2. Knez M, Glibetić M, Maxfield L, Crane JS. Zinc as a biomarker of cardiovascular health. Front Nutr. 2021; 8:686078. doi:10.3389/fnut.2021.686078
3. Rauf A, Akram M, Anwar H. Therapeutic potential of herbal medicine for the management of hyperlipidemia. Environ Sci Pollut Res Int. 2022;29(27):40281-301. doi:10.1007/s11356-022-19733-7
4. Mollazadeh H, Tavana E, Fanni G, Bo S, Banach M, Pirro M, et al. Effects of statins on mitochondrial path- ways. J Cachexia Sarcopenia Muscle. 2021;12(2): 237–51. doi:10.1002/jcsm.12654
5. Protic O, Bonfigli AR, Antonicelli R. Nutraceutical combinations in hypercholesterolemia: evidence from randomized, placebo-controlled clinical trials. Nutrients. 2021;13(9):3128. doi:10.3390/nu13093128
6. Pizzagalli MD, Bensimon A, Superti-Furga G. A guide to plasma membrane solute carrier proteins. FEBS J. 2021;288(9):2784–835. doi:10.1111/febs.15531
7. Tamura Y. The role of zinc homeostasis in the prevention of diabetes mellitus and cardiovascular diseases. J Atheroscler Thromb. 2021;28(11):1109–22. doi: 10. 5551/ jat.RV17057
8. Olechnowicz J, Tinkov A, Skalny A. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. J Physiol Sci. 2018; 68(1): 19–31. doi:10.1007/s12576-017-0571-7
9. Brunt EM, Kleiner DE, Carpenter DH, Rinella M. NAFLD: reporting histologic findings in clinical practice. J Hepatol. 2021;73(5):2028-38. doi: 10.1016/ j.jhep. 2021.07.00
10. Karam I, Ma N, Liu XW, Kong XJ, Zhao XL, Yang YJ, et al. Lowering effects of aspirin eugenol ester on blood lipids in rats with high fat diet. Lipids Health Dis. 2016;15(1):196. doi:10.1186/s12944-016-0369-2
11. Barman S, Srinivasan KJ. Attenuation of oxidative stress and cardioprotective effects of zinc supplemen- tation in experimental diabetic rats. Br J Nutr. 2017; 117 (3):335–50. doi:10.1017/S000711451600430X
12. Ali EMT. Atorvastatin and zinc combination mitigates high fat diet-induced biochemical and histopathological changes in the testis of male albino rat. Egypt Acad J Biol Sci. 2022;14(2):221-46. doi:10.21608/ eajbsd. 2022. 296883
13. Farooq M, Ali A, Islam NU, Niaz F. Effect of zinc supp- lement on glycemic control and lipid abnormalities in type 2 diabetes patients. Pak J Med Health Sci. 2020; 27(10):2036–44. doi:10.29309/TPMJ/2020.27.10. 4048
14. Payahoo L, Ostadrahimi A, Mobasseri M, Bishak YK, Farrin N, Jafarabadi M, et al. Effects of zinc supple- mentation on anthropometric measurements, lipid profiles and fasting blood glucose in healthy obese adults. Adv Pharm Bull. 2013;3(1):161-5. doi: 10. 5681/apb.2013.025
15. Iswendi I, Iryani I, Putra RF. Effect of virgin coconut oil from green coconut on high-density lipoprotein (HDL) levels in blood serum of white mice. EKSakta. 2021;2(2):2716-20. doi:10.20885/EKSAKTA. vol2.iss2.art10
16. Rahman MA, Amin MT, Arefin S. Evaluation of body weight, serum lipid profile, glucose homeostasis, oxi- dative stress and hepatic function in healthy mice fed with zinc sulphate supplementation. Dhaka Univ J Pharm Sci. 2021;20(1):1–9. doi:10.3329/ dujps. v20i1. 54033
17. Qi Y, Zhang Z, Liu S, Aluo Z. Zinc supplementation alleviates lipid and glucose metabolic disorders induced by a high-fat diet. J Agric Food Chem. 2020;68(18): 5189–200. doi:10.1021/acs.jafc.0c01103
18. Kim MC, Lee JI, Kim JH, Kim HJ, Cho YK, Jeon WK, et al. Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease. PLoS One. 2020; 15(10):e0240195. doi:10.1371/journal.pone.0240195
19. Barbara M, Mindikoglu AL. The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease. Metabol Open. 2021;11:100105. doi: 10. 1016/ j.metop.2021.100105
20. Zia AE, Yousaf N, Talha MU, Siddiqui W. Evaluation of the protective roles of canagliflozin and zinc sulphate on body weight and hepatic histology in diabetic dysli- pidemia. J Islamabad Med Dent Coll. 2024; 13(2): 1213. DOI: https://doi.org/10.35787/jimdc.v13i2.1195.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk